SecBot SecBot
PRESS-RELEASE ·Filed Sep 22, 2026

BMEA

Biomea Fusion, Inc.
BEARISH
Impact 5/10
Horizondays Processed1mo ago WireGlobeNewswire
Press release · Offering
Actionable Insight ▼ Bearish

Watch for the pricing and size of the offering in the preliminary prospectus supplement. The lack of disclosed terms suggests the company is testing market demand; a large discount or sizable offering relative to market cap could pressure the stock.

DirectionBearish
Confidencemedium
Horizondays
Latest settled — T+20d ⚠ clustered
BMEA ▼ -52.08% at T+20d
SHORT call ✓ call won +52.08% · α vs SPY +52.76% · entry $1.44 → $0.6901
Next anchor: T+60d in 7w
Latest observation: T+22 +62.56% FF3 residual α
Entry = T+0 close
Sep 22, 2026
via day close
T+1d
+3.47%
call -3.47% · α -3.55%
$1.49
settled 5w ago
T+5d
-7.64%
call +7.64% · α +6.96%
$1.33
settled 28d ago
T+20d
-52.08%
call +52.08% · α +52.76%
$0.6901
settled 7d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

Biomea Fusion announced an underwritten public offering of common stock and pre-funded warrants, with a 30-day underwriter option for an additional 15%. The offering size and pricing are undisclosed, creating near-term dilution uncertainty for a clinical-stage company with no approved products.

Key Facts

  • Biomea commenced an underwritten public offering of common stock and pre-funded warrants.
  • Underwriter has a 30-day option to purchase up to an additional 15% of the offering.
  • Konik Capital Partners, LLC is the sole underwriter.
  • Offering is made under an effective shelf registration statement (File No. 333-289262).
  • Offering size, pricing, and expected proceeds are not disclosed.

Financial Impact

Undisclosed amount; dilution to existing shareholders is certain but magnitude unknown.

dilutionshare count

Risk Factors

  • Dilution from the offering may depress share price.
  • Clinical-stage company with no approved products faces execution risk on pipeline (icovamenib, BMF-650).
  • Market conditions may lead to unfavorable pricing or cancellation of the offering.

Investment Themes

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3366878
14 reports for BMEA
Performance horizon
38% Hit rate @ T+5 3 of 8 directional calls Went positive at some point 6 of 8 best @ T+60▲ +56.52%Jun 5, 2026
Filters
Rows
Reports for BMEA — sortable, filterable
TypeNow
Oct 13, 2026
13d ago
8-K
BULLISH ★ 6/10
$0.8340 $0.6901▼ −17.25%▼ −17.71%$0.6360 (−23.74%)
Oct 13, 2026
13d ago
Press Release
NEUTRAL ★ 5/10
$0.8340 $0.6901▼ −17.25%▼ −17.71%$0.6360 (−23.74%)
Sep 23, 2026
4w ago
Press Release
BULLISH ★ 5/10
$1.44 $1.33▼ −7.64%▼ −6.96%$0.6360 (−55.83%)
Sep 22, 2026
4w ago
424B5
BEARISH ★ 6/10
$1.44 $1.33▲ +7.64%▲ +6.96%$0.6360 (+55.83%)
Sep 22, 2026
4w ago
Press Release
BEARISH ★ 5/10
$1.44 $1.33▲ +7.64%▲ +6.96%$0.6360 (+55.83%)
Jun 12, 2026
19w ago
Institutional Cluster
MIXED ★ 4/10
$1.17 $1.18▲ +0.85%▲ +0.18%$0.6360 (−45.64%)
Jun 5, 2026
20w ago
Press Release
BULLISH ★ 6/10
$1.15 $1.20▲ +4.35%▲ +2.24%$0.6360 (−44.70%)
May 11, 2026
24w ago
8-K
NEUTRAL ★ 4/10
$1.58 $1.25▼ −20.89%▼ −20.96%$0.6360 (−59.75%)
May 11, 2026
24w ago
Press Release
NEUTRAL ★ 5/10
$1.58 $1.25▼ −20.89%▼ −20.96%$0.6360 (−59.75%)
Apr 28, 2026
25w ago
8-K
BULLISH ★ 7/10
$1.53 $1.48▼ −3.27%▼ −4.96%$0.6360 (−58.43%)
Showing 10 of 14

US Market Status

Market Closed — Opens Wed (9h 36m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 22, 2026